Table 2.

Comparison of symptoms and comorbidities between SARS-CoV-2 positive groups with and without Hyposmia

	SARS-CoV-2-positive with Hyposmia (n = 23)	SARS-CoV-2-positive without Hyposmia (n = 19)	Odds ratio	p
Comorbidities
Immunosuppression	3 (13.0%)	4 (21.1%)	0.570 [0.039–5.074]	0.682
Pulmonary diseases	2 (8.7%)	3 (15.8%)	0.516 [0.132–2.748]	0.516
Arterial hypertension	13 (56.5%)	9 (47.3%)	1.432 [0.362–5.807]	0.757
Malignoma	1 (4.3%)	5 (26.3%)	0.133 [0.002–1.370]	0.075
Pollinosis	1 (4.3%)	1 (5.3%)	0.822 [0.009–67.719]	1.000
History of nicotin abuse	3 (13.0%)	6 (31.6%)	0.334 [0.046–1.901]	0.257
Symptoms
Sore throat	6 (26.1%)	0 (0.0%)	∞ [1.104–∞]	0.024
Fever	20 (87.0%)	15 (78.9%)	1.753 [0.254–13.820]	0.682
Tiredness	18 (78.3%)	10 (52.6%)	3.145 [0.711–15.631]	0.107
Cough	20 (87.0%)	9 (47.4%)	7.020 [1.377–49.542]	0.008
Myalgia	10 (43.5%)	3 (15.8%)	3.966 [0.795–27.147]	0.093
Cephalgia	10 (43.5%)	1 (5.3%)	13.082 [1.528–631.146]	0.006
Diarrhea	4 (17.4%)	0 (0.0%)	∞ [0.573–∞]	0.193
Emesis	2 (8.7%)	0 (0.0%)	∞ [0.156–∞]	0.493

Bold writing indicates p < 0.05 by Fisher’s exact test